MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1159/000075609

Медицинская библиотека · Onkologie · 2004

Suboccipital lateral injection of intrathecal chemotherapy in a patient with mantle cell lymphoma.

Ghareh Hussein, Alonso-Lozares Isis, Schetters Dustin, Herman Rae J, Heistek Tim S, Van Mourik Yvar, Jean-Richard-Dit-Bressel Philip, Zernig Gerald, Mansvelder Huibert D, De Vries Taco J, Marchant Nathan J

Клинический случайСтатьяПеревод пока не подготовлен

Аннотация

Background

Claudin 18.2 (CLDN18.2) has become a clinically relevant therapeutic target in gastric adenocarcinoma (GC), with zolbetuximab now approved for use in CLDN18.2-positive, HER2-negative advanced disease. The aim of this study was to evaluate the prevalence, intratumoral reproducibility, and clinicopathologic associations of CLDN18.2 expression in a Western cohort of resected GC.

Methods

CLDN18.2 expression was evaluated by immunohistochemistry in 204 resected GCs arranged in tissue microarrays containing duplicate tumor cores corresponding to the tumor center and invasive front. Correlations between paired cores, clinicopathologic parameters, additional biomarkers (E-cadherin, HER2, p53, mismatch repair (MMR)), and clinical outcomes were analyzed.

Results

Using the clinical cutoff, 29.9% of cases were CLDN18.2-positive. Inter-core reproducibility was excellent (93.8% concordance, κ = 0.871), indicating minimal intratumoral heterogeneity. CLDN18.2 positivity was consistently associated with male sex, an infiltrative invasive front and absence of necrosis (p < 0.05) and occurred more frequently in MMR-proficient tumors (p = 0.041 at the 50% cutoff). CLDN18.2-positive cases showed higher rates of strong diffuse membranous E-cadherin staining (p < 0.001). At the clinical cutoff, CLDN18.2-positive patients were younger (p = 0.049). No associations were found with HER2, p53, recurrence, or cancer-specific survival. However, tumors with extreme expression (Z-score ≥ 250; 14.4%) showed increased Borrmann type IV GC, lymphovascular invasion and cancer-related mortality (p = 0.038), with strengthened significance in stage III tumors (disease-specific survival, p = 0.026).

Conclusions

CLDN18.2 shows excellent intratumoral reproducibility and a stable biological profile in GC, supporting its diagnostic reliability in biopsies and value as a predictive biomarker. A subset with extreme expression demonstrated aggressive features, suggesting a potential "claudin-driven" phenotype requiring further study.

Для цитирования: Ghareh Hussein, Alonso-Lozares Isis, Schetters Dustin, Herman Rae J, Heistek Tim S, Van Mourik Yvar, Jean-Richard-Dit-Bressel Philip, Zernig Gerald, Mansvelder Huibert D, De Vries Taco J, Marchant Nathan J. Suboccipital lateral injection of intrathecal chemotherapy in a patient with mantle cell lymphoma.. Onkologie. 2004. DOI: 10.1159/000075609.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.